{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:21:04Z","timestamp":1772274064617,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00345-019-02723-9","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T06:35:26Z","timestamp":1552286126000},"page":"1035-1041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Peyronie\u2019s disease and testosterone deficiency: Is there a link?"],"prefix":"10.1007","volume":"37","author":[{"given":"Ishan","family":"Aditya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan D.","family":"Grober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonah","family":"Krakowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"issue":"4","key":"2723_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/andr.12058","volume":"3","author":"FA Yafi","year":"2015","unstructured":"Yafi FA, Pinsky MR, Sangkum P, Hellstrom WJ (2015) Therapeutic advances in the treatment of Peyronie\u2019s disease. Andrology 3(4):650\u2013660","journal-title":"Andrology"},{"issue":"1","key":"2723_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1743-6109.2004.10104.x","volume":"1","author":"TF Lue","year":"2004","unstructured":"Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R (2004) Summary of the recommendations on sexual dysfunctions in men. J Sexual Med 1(1):6\u201323","journal-title":"J Sexual Med"},{"issue":"2","key":"2723_CR3","doi-asserted-by":"publisher","first-page":"e0150157","DOI":"10.1371\/journal.pone.0150157","volume":"11","author":"M Stuntz","year":"2016","unstructured":"Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D (2016) The prevalence of Peyronie\u2019s disease in the United States: a population-based study. PLoS ONE 11(2):e0150157","journal-title":"PLoS ONE"},{"issue":"7","key":"2723_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","volume":"60","author":"T Mulligan","year":"2006","unstructured":"Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C (2006) Prevalence of hypogonadism in males aged at least 45\u00a0years: the HIM study. Int J Clin Pract 60(7):762\u2013769","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2723_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0025-6196(11)60963-4","volume":"82","author":"ER Bolona","year":"2007","unstructured":"Bolona ER, Uraga MV, Haddad RM, Tracz MJ, Tracz MJ, Sideras K (2007) Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82(1):20\u201328","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"2723_CR6","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FC Wu","year":"2008","unstructured":"Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O\u2019neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93(7):2737\u20132745","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2723_CR7","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/j.1743-6109.2008.00856.x","volume":"5","author":"G Corona","year":"2008","unstructured":"Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Forti G, Maggi M (2008) Low levels of androgens in men with erectile dysfunction and obesity. J Sexual Med 5(10):2454\u20132463","journal-title":"J Sexual Med"},{"issue":"7","key":"2723_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1506119","volume":"374","author":"PJ Snyder","year":"2016","unstructured":"Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE (2016) Effects of testosterone treatment in older men. N Engl J Med 374(7):611\u2013624","journal-title":"N Engl J Med"},{"issue":"1","key":"2723_CR9","first-page":"33","volume":"5","author":"ZJ Shen","year":"2003","unstructured":"Shen ZJ, Zhou XL, Lu YL, Chen ZD (2003) Effect of androgen deprivation on penile ultrastructure. Asian J Androl 5(1):33\u201336","journal-title":"Asian J Androl"},{"issue":"4","key":"2723_CR10","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1210\/endo.140.4.6655","volume":"140","author":"AM Traish","year":"1999","unstructured":"Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I (1999) Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140(4):1861\u20131868","journal-title":"Endocrinology"},{"issue":"7","key":"2723_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U (2001) The prevalence of Peyronie\u2019s disease: results of a large survey. BJU Int 88(7):727\u2013730","journal-title":"BJU Int"},{"key":"2723_CR12","unstructured":"Methods.cochrane.org (2019) Cochrane risk of bias tool. \n                    https:\/\/methods.cochrane.org\/bias\/resources\/cochrane-risk-bias-tool\n                    \n                  . Accessed 2 Jan 2019"},{"key":"2723_CR13","unstructured":"Evidencepartners.com (2018) \n                    https:\/\/www.evidencepartners.com\/wp-content\/uploads\/2017\/09\/Tool-to-Assess-Risk-of-Bias-in-Cohort-Studies.pdf"},{"issue":"6","key":"2723_CR14","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/j.1743-6109.2009.01250.x","volume":"6","author":"SA Moreno","year":"2009","unstructured":"Moreno SA, Morgentaler A (2009) PEYRONIE\u2019S DISEASE: testosterone deficiency and Peyronie\u2019s disease: pilot data suggesting a significant relationship. J Sexual Med 6(6):1729\u20131735","journal-title":"J Sexual Med"},{"issue":"11","key":"2723_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1442-2042.2011.02842.x","volume":"18","author":"HJ Nam","year":"2011","unstructured":"Nam HJ, Park HJ, Park NC (2011) Does testosterone deficiency exaggerate the clinical symptoms of Peyronie\u2019s disease? Int J Urol 18(11):796\u2013800","journal-title":"Int J Urol"},{"issue":"4","key":"2723_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0022-5347(09)60793-X","volume":"181","author":"R Sturm","year":"2009","unstructured":"Sturm R, Rumohr JA, Lipshultz LI, Mohamed O, Khera M (2009) Increased incidence of hypogonadism in patients with a novel diagnosis of Peyronie\u2019s disease as compared to organic erectile dysfunction. J Urol 181(4):278\u2013279","journal-title":"J Urol"},{"key":"2723_CR17","first-page":"455","volume":"6","author":"M Karavitakis","year":"2009","unstructured":"Karavitakis M, Komninos C, Kontos S, Simaioforidis V, Kachrilas S, Politis V, Chatziplis E, Koritsiadis G, Doumanis G (2009) Altered collagen metabolism in Peyronie\u2019s disease: is dehydroepiandrosterone sulfate the missing link?: po-07\u2013015. J Sexual Med 6:455\u2013456","journal-title":"J Sexual Med"},{"issue":"3","key":"2723_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2164\/jandrol.111.012948","volume":"33","author":"G Cavallini","year":"2012","unstructured":"Cavallini G, Biagiotti G, Giudice CL (2012) Association between Peyronie disease and low serum testosterone levels: detection and therapeutic considerations. J Androl 33(3):381\u2013388","journal-title":"J Androl"},{"issue":"3","key":"2723_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/jsm.12805","volume":"12","author":"EW Kirby","year":"2015","unstructured":"Kirby EW, Verges D, Matthews J, Carson CC, Coward RM (2015) Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie\u2019s disease or erectile dysfunction and does not correlate with Peyronie\u2019s disease severity. J Sexual Med 12(3):690\u2013696","journal-title":"J Sexual Med"},{"issue":"3","key":"2723_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/tau.2016.04.05","volume":"5","author":"S Al-Thakafi","year":"2016","unstructured":"Al-Thakafi S, Al-Hathal N (2016) Peyronie\u2019s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up. Transl Androl Urol 5(3):280","journal-title":"Transl Androl Urol"},{"issue":"1","key":"2723_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/0970-1591.173107","volume":"32","author":"AN Bilgutay","year":"2016","unstructured":"Bilgutay AN, Pastuszak AW (2016) Peyronie\u2019s disease: What\u2019s around the bend? Indian J Urol 32(1):6","journal-title":"Indian J Urol"},{"issue":"3","key":"2723_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/TGR.0000000000000106","volume":"32","author":"RS Rubin","year":"2016","unstructured":"Rubin RS, Goldstein I (2016) Medical management of sexual dysfunction in the aging male. Top Geriatr Rehabilit 32(3):167\u2013173","journal-title":"Top Geriatr Rehabilit"},{"key":"2723_CR23","unstructured":"Accessdata.fda.gov (2018) Drugs@FDA: FDA approved drug products\u2014Xiaflex. \n                    https:\/\/www.accessdata.fda.gov\n                    \n                  . Accessed 10 July 2018"},{"issue":"3","key":"2723_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","volume":"41","author":"M Shirazi","year":"2009","unstructured":"Shirazi M, Haghpanah AR, Badiee M, Afrasiabi MA, Haghpanah S (2009) Effect of intralesional verapamil for treatment of Peyronie\u2019s disease: a randomized single-blind, placebo-controlled study. Int Urol Nephrol 41(3):467\u2013471","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"2723_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0911101","volume":"363","author":"FC Wu","year":"2010","unstructured":"Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O\u2019neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363(2):123\u2013135","journal-title":"N Engl J Med"},{"issue":"6","key":"2723_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1023\/A:1025860214891","volume":"20","author":"\u00c5 Bratland","year":"2003","unstructured":"Bratland \u00c5, Ragnhildstveit E, Bj\u00f8rnland K, Andersen K, M\u00e6landsmo GM, Fodstad \u00d8, Saatcioglu F, Ree AH (2003) The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells. Clin Exp Metast 20(6):541","journal-title":"Clin Exp Metast"},{"issue":"5","key":"2723_CR27","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1210\/en.2002-0157","volume":"144","author":"X Liao","year":"2003","unstructured":"Liao X, Thrasher JB, Pelling J, Holzbeierlein J, Sang QX, Li B (2003) Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 144(5):1656\u20131663","journal-title":"Endocrinology"},{"issue":"4","key":"2723_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","volume":"177","author":"P Snyder","year":"2017","unstructured":"Snyder P, Kopperdahl D, Stephens-Shields A, Ellenberg S, Cauley J, Ensrud K et al (2017) Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone. JAMA Intern Med 177(4):471","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2723_CR29","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jamainternmed.2016.9540","volume":"177","author":"C Roy","year":"2017","unstructured":"Roy C, Snyder P, Stephens-Shields A, Artz A, Bhasin S, Cohen H et al (2017) Association of testosterone levels with anemia in older men. JAMA Intern Med 177(4):480","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2723_CR30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, Khera M, Kirkby E, McVary KT, Miner MM, Nelson CJ (2015) Peyronie\u2019s disease: AUA guideline. J Urol 194(3):745\u2013753","journal-title":"J Urol"},{"issue":"5","key":"2723_CR31","doi-asserted-by":"publisher","first-page":"E197","DOI":"10.5489\/cuaj.5255","volume":"12","author":"AJ Bella","year":"2018","unstructured":"Bella AJ, Lee JC, Grober ED, Carrier S, Benard F, Brock GB (2018) 2018 Canadian urological association guideline for Peyronie\u2019s disease and congenital penile curvature. Can Urol Assoc J 12(5):E197","journal-title":"Can Urol Assoc J"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02723-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:11:04Z","timestamp":1583799064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02723-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2723"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02723-9","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"27 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no personal conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}